Managing Director Corporate Strategy - Business De
Hillebrand brings over 40 years of pharmaceutical experience covering development, production and commercialization. He was until 2009 CEO of EBEWE Pharma, a business specializing in oncology and neurology, that he led and grew for 30 years until finally selling to Novartis. Friedrich holds a PhD in Chemical Engineering from the University of Vienna.
Pediatric Neurology & Diseases, Pediatric Cardiology, Pediatric Care